Main Street Group, LTD Kura Oncology, Inc. Transaction History
Main Street Group, LTD
- $208 Million
- Q2 2024
A detailed history of Main Street Group, LTD transactions in Kura Oncology, Inc. stock. As of the latest transaction made, Main Street Group, LTD holds 50 shares of KURA stock, worth $902. This represents 0.0% of its overall portfolio holdings.
Number of Shares
50
Previous 50
-0.0%
Holding current value
$902
Previous $1,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding KURA
# of Institutions
181Shares Held
80.2MCall Options Held
148KPut Options Held
63K-
Suvretta Capital Management, LLC New York, NY7.07MShares$128 Million6.08% of portfolio
-
Black Rock Inc. New York, NY6.97MShares$126 Million0.0% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA5.81MShares$105 Million4.23% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY5.41MShares$97.6 Million2.34% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY4.54MShares$81.9 Million3.78% of portfolio
About Kura Oncology, Inc.
- Ticker KURA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 66,893,000
- Market Cap $1.21B
- Description
- Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...